-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
TSCP has shown its effectiveness in controlling dizziness in refractory Meniere's disease
Meniere's disease patients undergoing TSCP surgery receive or do not receive dexamethasone treatment after surgery
The results showed that the hearing deterioration and word recognition score loss of the dexamethasone group was less than that of the non-dexamethasone group
In summary, the study results show that dexamethasone can protect the hearing of Meniere's patients after TSCP
Original source:
Yafeng Lyu, et al.
Dexamethasone protects the hearing of Meniere's disease patients after triple semicircular canal plugging
in this message